The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERON PHARMA INC | Common | 00434H108 | 99,081 | 1,040,000 | SH | SOLE | 1,040,000 | 0 | 0 | ||
| ADAPTIMMUNE THERAPEUTICS PLC | Sponsored ADR | 00653A107 | 100,100 | 10,000,000 | SH | SOLE | 10,000,000 | 0 | 0 | ||
| ADAPTIMMUNE THERAPEUTICS PLC | Sponsored ADR | 00653A107 | 70 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
| ADVERUM BIOTECHNOLOGIES INC | Common | 00773U108 | 158,375 | 7,585,000 | SH | SOLE | 7,585,000 | 0 | 0 | ||
| ALIMERA SCIENCES INC | Common | 016259202 | 2,621 | 415,999 | SH | SOLE | 415,999 | 0 | 0 | ||
| ALLOGENE THERAPEUTICS INC | Common | 019770106 | 48,326 | 1,128,594 | SH | SOLE | 1,128,594 | 0 | 0 | ||
| AMARIN CORP PLC | Sponsored ADR | 023111206 | 13,840 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | 165,880 | 11,000,000 | SH | SOLE | 11,000,000 | 0 | 0 | ||
| ARENA PHARMACEUTICALS INC | Common | 040047607 | 59,803 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
| ARGENX SE | Sponsored ADR | 04016X101 | 218,473 | 970,000 | SH | SOLE | 970,000 | 0 | 0 | ||
| ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 258,825 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
| ATHENEX INC | Common | 04685N103 | 52,976 | 3,850,000 | SH | SOLE | 3,850,000 | 0 | 0 | ||
| AURINIA PHARMACEUTICALS INC | Common | 05156V102 | 27,138 | 1,670,000 | SH | SOLE | 1,670,000 | 0 | 0 | ||
| AVADEL PHARMACEUTICALS PLC | Sponsored ADR | 05337M104 | 36,890 | 4,565,655 | SH | SOLE | 4,565,655 | 0 | 0 | ||
| AVIDITY BIOSCIENCES INC | Common | 05370A108 | 16,532 | 585,000 | SH | SOLE | 585,000 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL | Common | 09060J106 | 8,872 | 2,034,900 | SH | SOLE | 2,034,900 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 228,179 | 1,850,000 | SH | SOLE | 1,850,000 | 0 | 0 | ||
| BLACK DIAMOND THERAPEUTICS INC | Common | 09203E105 | 22,134 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | ||
| CARDIFF ONCOLOGY INC | Common | 14147L108 | 5,010 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| CONSTELLATION PHARMACEUTICALS INC | Common | 210373106 | 120,200 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
| CUE BIOPHARMA INC | Common | 22978P106 | 45,834 | 1,870,000 | SH | SOLE | 1,870,000 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | Common | 23257D103 | 18,323 | 5,250,000 | SH | SOLE | 5,250,000 | 0 | 0 | ||
| DECIPHERA PHARMACEUTICALS INC | Common | 24344T101 | 111,079 | 1,860,000 | SH | SOLE | 1,860,000 | 0 | 0 | ||
| FENNEC PHARMACEUTICALS INC | Common | 31447P100 | 13,945 | 1,670,000 | SH | SOLE | 1,670,000 | 0 | 0 | ||
| HORIZON THERAPEUTICS PLC | Common | G46188101 | 333,480 | 6,000,000 | SH | SOLE | 6,000,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | Common | 452907108 | 930,300 | 26,250,000 | SH | SOLE | 26,250,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | Common | 462260100 | 284,411 | 10,361,039 | SH | SOLE | 10,361,039 | 0 | 0 | ||
| IVERIC BIO INC | Common | 46583P102 | 36,210 | 7,100,000 | SH | SOLE | 7,100,000 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | Common | 48576U106 | 132,580 | 7,000,000 | SH | SOLE | 7,000,000 | 0 | 0 | ||
| KURA ONCOLOGY INC | Common | 50127T109 | 17,115 | 1,050,000 | SH | SOLE | 1,050,000 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | Common | 558868105 | 39,638 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| MARINUS PHARMACEUTICALS INC | Common | 56854Q101 | 30,378 | 11,960,000 | SH | SOLE | 11,960,000 | 0 | 0 | ||
| MERSANA THERAPEUTICS INC | Common | 59045L106 | 152,100 | 6,500,000 | SH | SOLE | 6,500,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | Common | 60468T105 | 489,420 | 4,286,765 | SH | SOLE | 4,286,765 | 0 | 0 | ||
| MYOKARDIA INC | Common | 62857M105 | 181,646 | 1,880,000 | SH | SOLE | 1,880,000 | 0 | 0 | ||
| PTC THERAPEUTICS INC | Common | 69366J200 | 16,478 | 324,750 | SH | SOLE | 324,750 | 0 | 0 | ||
| RELMADA THERAPEUTICS INC | Common | 75955J402 | 63,769 | 1,425,000 | SH | SOLE | 1,425,000 | 0 | 0 | ||
| RETROPHIN INC | Common | 761299106 | 21,431 | 1,050,000 | SH | SOLE | 1,050,000 | 0 | 0 | ||
| REVOLUTION MEDICINES INC | Common | 76155X100 | 9,597 | 304,000 | SH | SOLE | 304,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | Common | 803607100 | 268,570 | 1,675,000 | SH | SOLE | 1,675,000 | 0 | 0 | ||
| TRICIDA INC | Common | 89610F101 | 16,488 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | Common | 89620X506 | 38,428 | 4,750,000 | SH | SOLE | 4,750,000 | 0 | 0 | ||
| UNIQURE NV | Common | N90064101 | 67,590 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | Common | 98420N105 | 35,112 | 2,800,000 | SH | SOLE | 2,800,000 | 0 | 0 | ||
| ZOGENIX INC | Common | 98978L204 | 60,773 | 2,250,000 | SH | SOLE | 2,250,000 | 0 | 0 | ||